MapLight Therapeutics/$MPLT
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About MapLight Therapeutics
MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.
Ticker
$MPLT
Sector
Primary listing
Employees
114
Headquarters
Website
MPLT Metrics
BasicAdvanced
$903M
-
-$133.73
-
-
Price and volume
Market cap
$903M
52-week high
$21.40
52-week low
$12.24
Average daily volume
264K
Financial strength
Current ratio
13.215
Quick ratio
12.238
Long term debt to equity
2.203
Total debt to equity
2.572
Profitability
EBITDA (TTM)
-107.851
Management effectiveness
Valuation
Price to book
-45.97
Price to tangible book (TTM)
-45.97
Price to free cash flow (TTM)
-0.141
Free cash flow yield (TTM)
-709.92%
Free cash flow per share (TTM)
-146.948
Growth
What the Analysts think about MPLT
Analyst ratings (Buy, Hold, Sell) for MapLight Therapeutics stock.
MPLT Financial Performance
Revenues and expenses
MPLT Earnings Performance
Company profitability
MPLT News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for MapLight Therapeutics stock?
MapLight Therapeutics (MPLT) has a market cap of $903M as of December 16, 2025.
What is the P/E ratio for MapLight Therapeutics stock?
The price to earnings (P/E) ratio for MapLight Therapeutics (MPLT) stock is 0 as of December 16, 2025.
Does MapLight Therapeutics stock pay dividends?
No, MapLight Therapeutics (MPLT) stock does not pay dividends to its shareholders as of December 16, 2025.
When is the next MapLight Therapeutics dividend payment date?
MapLight Therapeutics (MPLT) stock does not pay dividends to its shareholders.
What is the beta indicator for MapLight Therapeutics?
MapLight Therapeutics (MPLT) does not currently have a Beta indicator.